341 related articles for article (PubMed ID: 24828101)
21. Phentermine and topiramate extended-release for the obesity: new kids on the block.
Katsi V; Marketou M; Kallistratos MS; Tousoulis D; Makris T; Manolis AJ; Vardas P; Kallikazaros I
Recent Pat Cardiovasc Drug Discov; 2013 Apr; 8(1):35-41. PubMed ID: 23565717
[TBL] [Abstract][Full Text] [Related]
22. Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand?
Tak YJ; Lee SY
Curr Obes Rep; 2021 Mar; 10(1):14-30. PubMed ID: 33410104
[TBL] [Abstract][Full Text] [Related]
23. Fixed-dose combination of phentermine-topiramate for the treatment of obesity.
Halpern B; Faria AM; Halpern A
Expert Rev Clin Pharmacol; 2013 May; 6(3):235-41. PubMed ID: 23656337
[TBL] [Abstract][Full Text] [Related]
24. Overview of new antiobesity drugs.
Hainer V
Expert Opin Pharmacother; 2014 Oct; 15(14):1975-8. PubMed ID: 25100293
[TBL] [Abstract][Full Text] [Related]
25. Phentermine and topiramate extended-release: a new treatment for obesity and its role in a complications-centric approach to obesity medical management.
Garvey WT
Expert Opin Drug Saf; 2013 Sep; 12(5):741-56. PubMed ID: 23738843
[TBL] [Abstract][Full Text] [Related]
26. 2 new drugs for weight loss.
Med Lett Drugs Ther; 2012 Sep; 54(1398):69-71. PubMed ID: 22992487
[No Abstract] [Full Text] [Related]
27. Combination phentermine/topiramate for obesity treatment in primary care: a review.
Xiong GL; Gadde KM
Postgrad Med; 2014 Mar; 126(2):110-6. PubMed ID: 24685974
[TBL] [Abstract][Full Text] [Related]
28. Phentermine/topiramate for weight reduction and treatment of adverse metabolic consequences in obesity.
Bays HE; Gadde KM
Drugs Today (Barc); 2011 Dec; 47(12):903-14. PubMed ID: 22348915
[TBL] [Abstract][Full Text] [Related]
29. The FDA's assessment of two drugs for chronic weight management.
Colman E; Golden J; Roberts M; Egan A; Weaver J; Rosebraugh C
N Engl J Med; 2012 Oct; 367(17):1577-9. PubMed ID: 23050510
[No Abstract] [Full Text] [Related]
30. Market watch: upcoming market catalysts in Q3 2010.
Hay M
Nat Rev Drug Discov; 2010 Jul; 9(7):507. PubMed ID: 20592737
[No Abstract] [Full Text] [Related]
31. Treatment of obesity in 2015.
Shukla AP; Buniak WI; Aronne LJ
J Cardiopulm Rehabil Prev; 2015; 35(2):81-92. PubMed ID: 25714749
[TBL] [Abstract][Full Text] [Related]
32. Long-term effects of weight-reducing drugs in people with hypertension.
Siebenhofer A; Jeitler K; Horvath K; Berghold A; Posch N; Meschik J; Semlitsch T
Cochrane Database Syst Rev; 2016 Mar; 3():CD007654. PubMed ID: 26934640
[TBL] [Abstract][Full Text] [Related]
33. Pharmacotherapy of obesity: clinical treatments and considerations.
Holes-Lewis KA; Malcolm R; O'Neil PM; Hermayer K
Am J Med Sci; 2013 Apr; 345(4):284-288. PubMed ID: 23531960
[TBL] [Abstract][Full Text] [Related]
34. New pharmacological approaches for obesity management.
Rueda-Clausen CF; Padwal RS; Sharma AM
Nat Rev Endocrinol; 2013 Aug; 9(8):467-78. PubMed ID: 23752772
[TBL] [Abstract][Full Text] [Related]
35. Pharmacotherapy of Obesity: Clinical Trials to Clinical Practice.
Gadde KM; Pritham Raj Y
Curr Diab Rep; 2017 May; 17(5):34. PubMed ID: 28378293
[TBL] [Abstract][Full Text] [Related]
36. Lorcaserin, phentermine topiramate combination, and naltrexone bupropion combination for weight loss: the 15-min challenge to sort these agents out.
Citrome L
Int J Clin Pract; 2014 Dec; 68(12):1401-5. PubMed ID: 25418525
[No Abstract] [Full Text] [Related]
37. Safety assessment of combination therapies in the treatment of obesity: focus on naltrexone/bupropion extended release and phentermine-topiramate extended release.
Halpern B; Mancini MC
Expert Opin Drug Saf; 2017 Jan; 16(1):27-39. PubMed ID: 27732121
[TBL] [Abstract][Full Text] [Related]
38. New medications for obesity management: changing the landscape of obesity treatment.
Boulghassoul-Pietrzykowska N; Franceschelli J; Still C
Curr Opin Endocrinol Diabetes Obes; 2013 Oct; 20(5):407-11. PubMed ID: 23974768
[TBL] [Abstract][Full Text] [Related]
39. Pharmacologic Approaches to Weight Management: Recent Gains and Shortfalls in Combating Obesity.
Saunders KH; Kumar RB; Igel LI; Aronne LJ
Curr Atheroscler Rep; 2016 Jul; 18(7):36. PubMed ID: 27181165
[TBL] [Abstract][Full Text] [Related]
40. New developments in the pharmacologic treatment of obesity.
Fantasia HC
Nurs Womens Health; 2013; 17(1):53-62. PubMed ID: 23399013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
